Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04351893 · ClinicalTrials.gov registry record
Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology
A clinical trial of Microtia and Microtia-Anotia, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- 935
- Enrollment target
- 10
- Study locations
NCT04351893 is a study of Microtia and Microtia-Anotia that has completed, run by Seattle Children's Hospital. The registered enrollment target is 935 participants, below the 1,399-participant average among 4 other Microtia trials with a reported enrollment target (33% lower). The trial reports 10 study locations across 5 states.
The verdict
NCT04351893, a study of Microtia and Microtia-Anotia, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- 935 participants
- Enrollment target
- 10
- Study locations
Study Summary
The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliva) and are asked to upload a few photos of their face. Parents are asked a short interview. Participants are able to participate from home or at one of four domestic sites.
Conditions Studied
Study Locations (10)
Other
- Pontificia Universidad Javeriana - Bogotá
- ICESI - Cali
- Pontificia Universidad Javeriana - Cali
- Clínica Comfamiliar Risaralda - Pereira
- Hospital Edgardo Rebagliati Martins - Lima
- Instituto de Genética Médica y Molecular (INGEMM) - Madrid
California
- Children's Hospital Los Angeles - Los Angeles
North Carolina
- University of North Carolina - Chapel Hill
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 935 participants |
| Start Date | 2018-02-23 |
| Est. Completion | 2023-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04351893
The ClinicalTrials.gov registry entry for NCT04351893 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 935 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,399-participant average among 4 other Microtia trials with a reported enrollment target (33% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Microtia appearing as the primary indexed condition, and to 0 interventions.
NCT04351893 reports 10 study locations spanning 5 distinct geographic areas - top geographies include Other, California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04351893 about?
NCT04351893 is a clinical study titled "Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology". The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliv...
What is the current status of trial NCT04351893?
This trial is currently completed. The enrollment target is 935 participants. The study started on 2018-02-23. Estimated completion is 2023-08-30.
What conditions does trial NCT04351893 study?
This clinical trial studies the following conditions: Microtia, Microtia-Anotia, Craniofacial Microsomia, Hemifacial Microsomia, Goldenhar Syndrome.
Who is sponsoring clinical trial NCT04351893?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04351893 being conducted?
This trial has 10 study locations across California, North Carolina, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microtia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
RECRUITING
-
Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction
RECRUITING · NA
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.